Determination of L-selectin in blood plasma using DNA aptamer–based surface-enhanced Raman spectroscopy assay
- 9 January 2024
- journal article
- research article
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 416 (5) , 1-9
Abstract
In the human body, tumor cell occurrence can be indirectly monitored using the L-selectin concentration in the blood, since selectin ligands are present on the surface of tumor cells, and with tumor progression, a decrease in L-selectin levels can be expected and observed. In this study, we present a selective DNA-based surface-enhanced Raman spectroscopy (SERS) assay for the detection and determination of L-selectin in biological samples. Two calibration curves (linear in the 40–190 ng mL−1 region and exponential in the 40–500 ng mL−1 region) are fitted to the obtained SERS experimental data, i.e., the ratio of I732/I1334 band intensities (LOQ = 46 ng mL−1). Calculated determination coefficients are found to be R2 = 0.997 for the linear region of the calibration curve and R2 = 0.977 for the exponential region. Moreover, we demonstrate very good selectivity of the assay even in the presence of P- and E-selectin in a sample containing L-selectin. With our SERS assay, the L-selectin concentration in biological samples can be estimated directly from the calibration curves. Graphical abstractKeywords
This publication has 25 references indexed in Scilit:
- Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defenseCellular and Molecular Life Sciences, 2014
- Quantifying SERS enhancementsMRS Bulletin, 2013
- Nanotextured substrates with immobilized aptamers for cancer cell isolation and cytologyCancer, 2011
- Getting to the site of inflammation: the leukocyte adhesion cascade updatedNature Reviews Immunology, 2007
- The inflammatory response in strokeJournal of Neuroimmunology, 2007
- Increased levels of serum soluble L-selectin in unmedicated patients with schizophreniaSchizophrenia Research, 2007
- Costimulation of T‐cell proliferation by anti‐l‐selectin antibody is associated with the reduction of a cdk inhibitor p27Immunology, 2005
- Ligands for L-Selectin: Homing, Inflammation, and BeyondAnnual Review of Immunology, 2004
- P-selectin Glycoprotein Ligand-1 Mediates L-Selectin–dependent Leukocyte Rolling in VenulesJournal of Experimental Medicine, 2003
- Time course of ICAM-1 expression and leukocyte subset infiltration in rat forebrain ischemiaMolecular and Chemical Neuropathology, 1995